TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bohus BioTech AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
57,868
|
57,979
|
23,916 |
| Financial expenses |
3,639
|
52
|
1,391 |
| Earnings before taxes |
-49,878
|
48,454
|
-91,282 |
| EBITDA |
-45,163
|
49,711
|
-63,413 |
| Total assets |
123,247
|
63,789
|
52,431 |
| Current assets |
92,435
|
45,736
|
43,541 |
| Current liabilities |
16,828
|
19,775
|
53,007 |
| Equity capital |
35,442
|
43,296
|
-54,255 |
| - share capital |
1,031
|
1,013
|
946 |
| Employees (average) |
30
|
29
|
39 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
28.8%
|
67.9%
|
-103.5% |
| Turnover per employee |
1,929
|
1,999
|
613 |
| Profit as a percentage of turnover |
-86.2%
|
83.6%
|
-381.7% |
| Return on assets (ROA) |
-37.5%
|
76.0%
|
-171.4% |
| Current ratio |
549.3%
|
231.3%
|
82.1% |
| Return on equity (ROE) |
-140.7%
|
111.9%
|
168.2% |
| Change turnover |
-1,156
|
32,365
|
-59,569 |
| Change turnover % |
-2%
|
126%
|
-71% |
| Chg. No. of employees |
1
|
-10
|
-10 |
| Chg. No. of employees % |
3%
|
-26%
|
-20% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.